Path to a Cure (PTAC) - Postdoc-to-Faculty Transition Award Grant

Path to a Cure (PTAC) - Postdoc-to-Faculty Transition Award Grant

Status: ACTIVE
Funder: Cystic Fibrosis Foundation
Amount: Up to US $86,000
Last Updated: July 09, 2025

Summary

The Path to a Cure (PTAC) - Postdoc-to-Faculty Transition Award by the Cystic Fibrosis Foundation supports postdoctoral fellows in advancing their research careers in cystic fibrosis. This program offers up to five years of funding, including 3 years for research training and 2 years for transitioning to an independent faculty position, with a maximum support of $110,000 per year. It aims to foster innovative research that develops new therapies for cystic fibrosis.

Overview

About the Cystic Fibrosis Foundation The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with CF the opportunity to lead long, fulfilling lives by funding research and drug development, partnering with the CF community, and advancing high-quality, specialized care. To achieve this mission, various types of grants and awards are offered to support meritorious research in CF. Path to a Cure (PTAC) - Postdoc-to-Faculty Transition Award Program and Award Overview Path to a Cure: Postdoc-to-Faculty Transition Awards are designed to support postdoctoral research fellows during their CF fellowship and aid in their transition to an independent research faculty position. Candidates for this award can be identified any time during the first four years of their postdoctoral fellowship. Research projects proposed through this program should seek to develop new information that contributes to the development of new therapies for CF, especially projects focused on advancing CFTR repair and replacement strategies. Projects supported through the PTAC initiative should focus on foundational concepts, strategies, novel tools and methods, and/or technologies that have the potential to inform or ultimately translate into novel therapies to restore CFTR protein function or fix/replace the defective CFTR gene. Awards can provide individuals up to five (5) years of combined support for their research training (maximum of 3 years, known as “Phase I”) and the initiation of their independent research career (2 years, known as “Phase II”). It is anticipated that the award will provide the opportunity for awardees to hone research skills, develop into independent investigators, and initiate an independent CF research program. The maximum level of support available under this program during Phase I is $86,000. The faculty phase of the award (Phase II) includes $80,000 for salary support and $30,000 for research support, for a maximum level of support of $110,000 per year.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.